Search Results - "Kalinyak, Judith E"

Refine Results
  1. 1

    Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT by Kalinyak, Judith E., Berg, Wendie A., Schilling, Kathy, Madsen, Kathleen S., Narayanan, Deepa, Tartar, Marie

    “…Purpose To compare the performance characteristics of positron emission mammography (PEM) with those of whole-body PET (WBPET) and PET/CT in women with newly…”
    Get full text
    Journal Article
  2. 2

    Breast Cancer: Comparative Effectiveness of Positron Emission Mammography and MR Imaging in Presurgical Planning for the Ipsilateral Breast by BERG, Wendie A, MADSEN, Kathleen S, SCHILLING, Kathy, TARTAR, Marie, PISANO, Etta D, HOVANESSIAN LARSEN, Linda, NARAYANAN, Deepa, OZONOFF, Al, MILLER, Joel P, KALINYAK, Judith E

    Published in Radiology (2011)
    “…To determine the performance of positron emission mammography (PEM), as compared with magnetic resonance (MR) imaging, including the effect on surgical…”
    Get full text
    Journal Article
  3. 3

    Interpretation of Positron Emission Mammography: Feature Analysis and Rates of Malignancy by NARAYANAN, Deepa, MADSEN, Kathleen S, KALINYAK, Judith E, BERG, Wendie A

    Published in American journal of roentgenology (1976) (01-04-2011)
    “…The purpose of our study was to define and illustrate standard terminology for describing findings on positron emission mammography (PEM) and provide…”
    Get full text
    Journal Article
  4. 4

    Interpretation of Positron Emission Mammography and MRI by Experienced Breast Imaging Radiologists: Performance and Observer Reproducibility by NARAYANAN, Deepa, MADSEN, Kathleen S, KALINYAK, Judith E, BERG, Wendie A

    Published in American journal of roentgenology (1976) (01-04-2011)
    “…In preparation for a multicenter trial of positron emission mammography (PEM) and MRI in women with newly diagnosed cancer, the two purposes of this study were…”
    Get full text
    Journal Article
  5. 5

    Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging by Schilling, Kathy, Narayanan, Deepa, Kalinyak, Judith E., The, Juliette, Velasquez, Maria Victoria, Kahn, Simone, Saady, Matthew, Mahal, Ravinder, Chrystal, Larraine

    “…Purpose The objective of this study was to compare the performance characteristics of 18 F-fluorodeoxyglucose (FDG) positron emission mammography (PEM) with…”
    Get full text
    Journal Article
  6. 6

    Comparative Effectiveness of Positron Emission Mammography and MRI in the Contralateral Breast of Women With Newly Diagnosed Breast Cancer by BERG, Wendie A, MADSEN, Kathleen S, SCHILLING, Kathy, TARTAR, Marie, PISANO, Etta D, HOVANESSIAN LARSEN, Linda, NARAYANAN, Deepa, KALINYAK, Judith E

    “…The objective of our study was to compare the performance of positron emission mammography (PEM) with that of MRI in the evaluation of the contralateral breast…”
    Get full text
    Journal Article
  7. 7

    PET-guided breast biopsy by Kalinyak, Judith E, Schilling, Kathy, Berg, Wendie A, Narayanan, Deepa, Mayberry, Jennifer P, Rai, Rajesh, Dupree, Elizabeth B, Shusterman, Denise K, Gittleman, Mark A, Luo, Weidong, Matthews, Chris G

    Published in The breast journal (01-03-2011)
    “…Molecular imaging, using positron emission tomography (PET), has become an integral step in the evaluation of many patients with malignancy. However, its use…”
    Get more information
    Journal Article
  8. 8

    F-18 FDG PET/CT in the Management of Thyroid Cancer by Iagaru, Andrei, Kalinyak, Judith E, McDougall, I Ross

    Published in Clinical nuclear medicine (01-09-2007)
    “…PURPOSE:There are approximately 32,000 new cases of thyroid carcinoma annually in the United States. F-18 FDG PET/CT has an established role in cancer…”
    Get full text
    Journal Article
  9. 9

    Burkitt's lymphoma presenting as a rapidly growing thyroid mass by Kalinyak, Judith E, Kong, Christina S, McDougall, I Ross

    Published in Thyroid (New York, N.Y.) (01-10-2006)
    “…A 53-year-old man was admitted to the hospital because of tracheal compressive symptoms from a rapidly expanding thyroid mass. The patient first noticed the…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Clinical implications of the differences between diagnostic 123I and post-therapy 131I scans by Cohen, Jason B, Kalinyak, Judith E, Ross McDougall, I

    Published in Nuclear medicine communications (01-02-2004)
    “…BACKGROUNDI has been promoted for diagnostic imaging as a means of avoiding ‘stunning’. It has also been suggested that the more favourable physical…”
    Get full text
    Journal Article
  12. 12

    Dietary sodium modulates mRNA abundance of enzymes involved in pituitary processing of proopiomelanocortin by Chandramohan, G, Ni, X P, Kalinyak, J E, Humphreys, M H

    Published in Pituitary (01-09-2001)
    “…The messenger RNA abundance of proopiome-lanocortin (POMC) is increased in neurointermediate lobe (NIL) of rat pituitary when ingesting a high sodium diet (8%;…”
    Get full text
    Journal Article
  13. 13

    Dietary Sodium Intake Modulates Pituitary Proopiomelanocortin mRNA Abundance by Mayan, Haim, Ling, Kok-Tong, Lee, Eva Y, Wiedemann, Eckehart, Kalinyak, Judith E, Humphreys, Michael H

    Published in Hypertension (Dallas, Tex. 1979) (01-08-1996)
    “…The pituitary prohormone proopiomelanocortin gives rise to melanocortins of alpha, beta, and gamma primary structure in addition to corticotropin…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Tissue-specific regulation of insulin receptor mRNA levels in rats with STZ-induced diabetes mellitus by SECHI, L. A, GRIFFIN, C. A, GRADY, E. F, GRUNFELD, C, KALINYAK, J. E, SCHAMBELAN, M

    Published in Diabetes (New York, N.Y.) (01-09-1992)
    “…In rats with STZ-induced diabetes mellitus, a reduction in insulin secretion is associated with increased insulin binding in the liver, muscle, fat, and…”
    Get full text
    Journal Article
  16. 16

    Breast Cancer: Comparative Effectiveness of Positron Emission Mammography and MR Imaging in Presurgical Planning for the Ipsilateral Breast1 by Berg, Wendie A., Madsen, Kathleen S., Schilling, Kathy, Tartar, Marie, Pisano, Etta D., Larsen, Linda Hovanessian, Narayanan, Deepa, Ozonoff, Al, Miller, Joel P., Kalinyak, Judith E.

    Published in Radiology (01-01-2011)
    “…Overall, 61 (16%) of 388 participants had an appropriate change in surgical management based on MR findings—more than the 41 (11%) participants with an…”
    Get full text
    Journal Article
  17. 17

    Expression of AT2 receptors in the developing rat fetus by GRADY, E. F, SECHI, L. A, GRIFFIN, C. A, SCHAMBELAN, M, KALINYAK, J. E

    Published in The Journal of clinical investigation (01-09-1991)
    “…Angiotensin II is known primarily for its effects on blood pressure and electrolyte homeostasis, but recent studies suggest that angiotensin II may play a role…”
    Get full text
    Journal Article
  18. 18

    Characterization of angiotensin II receptor subtypes in rat heart by SECHI, L. A, GRIFFIN, C. A, GRADY, E. F, KALINYAK, J. E, SCHAMBELAN, M

    Published in Circulation research (01-12-1992)
    “…Angiotensin II exerts positive inotropic and chronotropic effects on the mammalian heart by binding to specific membrane receptors. Recently, two subtypes of…”
    Get full text
    Journal Article
  19. 19

    Distribution of angiotensin II receptor subtypes in rat and human kidney by Sechi, L A, Grady, E F, Griffin, C A, Kalinyak, J E, Schambelan, M

    Published in The American journal of physiology (01-02-1992)
    “…Angiotensin II initiates a variety of physiological effects in the kidney by binding to high-affinity receptors on plasma membranes. Recently, two subtypes of…”
    Get full text
    Journal Article
  20. 20

    Tissue specific expression of vascular smooth muscle angiotensin II receptor subtypes during ovine pregnancy by Cox, B E, Rosenfeld, C R, Kalinyak, J E, Magness, R R, Shaul, P W

    Published in The American journal of physiology (01-07-1996)
    “…Uteroplacentral responses to infused angiotensin II (ANG II) are less than those elicited by systemic vasculature. This does not reflect ANG II receptor (AT)…”
    Get full text
    Journal Article